399) A 65 year old man with history of diabetes mellitus is evaluated in your office during a routine follow-up visit. He does not have any complaints. He uses Glyburide and Metformin for his diabetes and Atorvastatin 80mg/day and Omega-3 Fatty Acids for his dyslipidemia. He is compliant with diet and exercise. His weight has been stable. He does not smoke or consume alcohol. His most recent HgbA1C was 6.0% and a fasting lipid panel a month ago showed Total cholesterol of 125 mg%, LDL-C 70mg%, Triglycerides 100mg% and HDL-C 35mg%. You discuss with him that his lipid panel meets the recommendations with regard to LDL cholesterol and Non-HDL cholesterol goals. However, he insists that he be treated for his low HDL-cholesterol. You offer adding Niacin but after he heard about it’s side effects he refuses it and seeks alternatives. Which of the following is the most appropriate recommendation for him?
A) Change Atorvastatin to Rosuvastatin
B) Add Cholestyramine
C) No further therapy
D) Discontinue Omega-3 Fatty Acids
E) Increase Atorvastatin
C
I will go with
C) No further therapy
Statin only mildly raise HDL cholesterol.
Cholestyramine does not increase HDL cholesterol.
Omega 3 fatty acid increase HDL cholesterol.
C
c???
C
C) No further therapy
A at first u can not leave patient with saying no further treat when he ask for something to increase HDL
It is found the rousovastatin increase HDL 11% in comparison with atrovestatin 5% only